Medicine and Dentistry
Acromegaly
26%
Adenoma
14%
Anal Cancer
26%
Biological Marker
27%
Body Mass Index
90%
Breast Cancer
17%
Cancer Risk
86%
Carcinoembryonic Antigen
11%
Chemoradiotherapy
36%
Cohort Analysis
22%
Colon Cancer
12%
Colonoscopy
16%
Colorectal Cancer
84%
Colorectal Liver Metastasis
15%
Colorectal Tumor
14%
Cytoreductive Surgery
40%
Diabetes
28%
Diseases
30%
Endometrial Cancer
26%
Growth Hormone
16%
Hazard Ratio
29%
Hyperthermic Intraperitoneal Chemotherapy
25%
Intraperitoneal Chemotherapy
15%
Lymph Node
11%
Malignant Neoplasm
100%
Maturity Onset Diabetes of the Young
15%
Meta-Analysis
51%
Meta-Regression
12%
Metastatic Carcinoma
12%
Minoxidil
16%
Neoplasm
66%
Obesity
48%
Observational Study
12%
Overall Survival
31%
Patient Referral
12%
Pelvic Exenteration
16%
Peritoneum Metastasis
14%
Pleomorphic Adenoma
16%
Preoperative Chemotherapy
20%
Prevalence
15%
Proportional Hazards Model
15%
Prospective Study
13%
Protein Binding
12%
Pseudomyxoma Peritonei
21%
Radiation Therapy
16%
Rectum Cancer
57%
Recurrent Disease
15%
Somatomedin B
12%
Somatomedin C
30%
Surgery
36%
Pharmacology, Toxicology and Pharmaceutical Science
Acromegaly
20%
Adenoma
7%
All Cause Mortality
6%
Anus Cancer
26%
Atherosclerosis
5%
Binding Protein
13%
Biological Marker
27%
Breast Cancer
17%
Cancer Incidence
9%
Cancer Mortality
9%
Carcinoembryonic Antigen
7%
Carcinogenesis
6%
Cardiovascular Disease
8%
Case-Control Study
6%
Chemotherapy
24%
Cohort Study
22%
Colon Cancer
15%
Colorectal Cancer
73%
Colorectal Carcinoma
7%
Cytokeratin 18
8%
Disease
19%
Endometrium Cancer
9%
Enzyme-Linked Immunosorbent Assay
5%
Growth Hormone
7%
Insulin Analog
6%
Intraperitoneal Chemotherapy
10%
Malignant Neoplasm
83%
Neoplasm
34%
Non Insulin Dependent Diabetes Mellitus
5%
Obesity
34%
Observational Study
10%
Overall Survival
18%
Oxaliplatin
9%
Parotid Gland Cancer
5%
Peritoneum Metastasis
13%
Pharmacodynamics
8%
Prevalence
11%
Progression Free Survival
6%
Prospective Study
7%
Prostate Cancer
11%
Randomized Clinical Trial
6%
Rectum Cancer
29%
Recurrent Disease
12%
Replacement Therapy
6%
Sex Hormone
7%
Somatomedin
10%
Somatomedin B
12%
Somatomedin Binding Protein 2
11%
Somatomedin C
17%
Squamous Cell Carcinoma
15%